| 2023Q3 | 2022Q3 | 2021Q3 | 2020Q3 | 2019Q3 | 2018Q3 | 2017Q3 | 2016Q3 | 2015Q3 | 2014Q3 |
| 每股指标_元 |
| 基本每股收益 | 2.72 | 3.50 | 5.25 | 1.55 | 1.10 | 0.68 | 0.18 | | 0.10 | 0.17 |
| 扣非每股收益 | 2.66 | 3.49 | 5.26 | 1.55 | 1.12 | 0.68 | 0.17 | | 0.19 | 0.17 |
| 稀释每股收益 | 2.72 | 3.50 | 5.25 | 1.55 | 1.10 | 0.68 | 0.18 | | 0.10 | 0.17 |
| 每股净资产 | 12.49 | 13.94 | 9.91 | 4.64 | 3.21 | 2.39 | 1.74 | 1.56 | 3.05 | 3.07 |
| 每股资本公积 | 0.02 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 1.27 | 1.28 |
| 每股未分配利润 | 11.13 | 12.31 | 8.29 | 3.22 | 1.91 | 1.19 | 0.56 | 0.38 | 0.81 | 0.71 |
| 每股经营现金流 | 1.08 | 0.62 | 5.20 | 1.54 | 0.35 | | 0.07 | | -0.05 | -0.02 |
| 成长能力 |
| 营业总收入 | 392.72亿 | 278.23亿 | 218.29亿 | 110.50亿 | 76.66亿 | 34.95亿 | 7.69亿 | 2.73亿 | 5.55亿 | 5.77亿 |
| 毛利润 | 111.03亿 | 92.37亿 | 117.91亿 | 44.22亿 | 32.15亿 | 19.87亿 | 6.77亿 | 2.53亿 | 4.26亿 | 3.55亿 |
| 归母净利润 | 65.30亿 | 56.07亿 | 84.04亿 | 24.79亿 | 17.63亿 | 10.87亿 | 2.85亿 | 676.13万 | 1.60亿 | 1.37亿 |
| 扣非净利润 | 63.80亿 | 55.90亿 | 84.18亿 | 24.83亿 | 17.98亿 | 10.95亿 | 2.80亿 | 347.29万 | 1.56亿 | 1.35亿 |
| 营业总收入同比 | 41.15% | 27.46% | 97.55% | 44.14% | 119.35% | 354.44% | 181.46% | -50.79% | -3.80% | -0.53% |
| 归母净利润同比 | 16.46% | -33.28% | 239.05% | 40.59% | 62.25% | 280.95% | 4118.66% | -95.79% | 17.23% | 4.09% |
| 扣非净利润同比 | 14.13% | -33.59% | 239.06% | 38.11% | 64.17% | 291.63% | 7951.12% | -97.77% | 15.50% | 5.53% |
| 滚动营业总收入环比 | 12.08% | 2.27% | 21.53% | 11.39% | 14.70% | 37.02% | 33.18% | -15.88% | -3.24% | 5.71% |
| 滚动归母净利润环比 | 4.86% | -12.25% | 26.61% | 13.15% | 11.05% | 30.84% | 61.75% | -56.90% | 7.08% | 9.47% |
| 滚动扣非净利润环比 | 3.60% | -12.33% | 26.60% | 12.80% | 10.80% | 31.50% | 63.37% | -60.98% | 6.99% | 10.05% |
| 盈利能力 |
| ROE(加权) | 24.14% | 27.99% | 67.98% | 35.93% | 36.76% | 31.85% | 10.74% | 0.27% | 6.41% | 5.64% |
| 总资产收益率 | 14.96% | 16.92% | 39.60% | 18.46% | 19.92% | 21.02% | 9.18% | 0.25% | 6.04% | 5.25% |
| ROIC(加权) | 21.60% | 26.22% | 60.83% | 26.74% | 28.91% | 27.60% | 10.87% | -0.29% | 5.60% | 4.76% |
| 毛利率 | 28.27% | 33.20% | 54.01% | 40.02% | 41.94% | 56.87% | 87.98% | 92.73% | 76.67% | 61.48% |
| 净利率 | 16.63% | 20.15% | 38.50% | 22.43% | 23.00% | 31.09% | 37.09% | 2.47% | 28.91% | 23.72% |
| 收益质量 |
| 预收账款/营业收入 | | | 0.01 | | | | | 0.01 | | |
| 经营现金流入/营业收入 | 0.82 | 0.81 | 0.86 | 0.79 | 0.70 | 0.70 | 0.73 | 1.24 | 0.89 | 0.87 |
| 经营现金流入/净利润 | 4.91 | 4.01 | 2.23 | 3.52 | 3.05 | 2.24 | 1.96 | 50.31 | 3.08 | 3.66 |
| 经营净现金流/净利润 | 0.40 | 0.18 | 0.99 | 1.00 | 0.32 | | 0.38 | -1.14 | -0.23 | -0.14 |
| 经营净现金流/营业收入 | 0.07 | 0.04 | 0.38 | 0.22 | 0.07 | | 0.14 | -0.03 | -0.07 | -0.03 |
| 销售现金流入/营业收入 | 0.81 | 0.80 | 0.85 | 0.78 | 0.70 | 0.69 | 0.70 | 0.98 | 0.82 | 0.80 |
| 销售净现金流/营业收入 | 0.19 | 0.80 | 0.85 | 0.78 | 0.70 | 0.69 | 0.70 | 0.98 | 0.82 | 0.80 |
| 实际税率 | 14.29% | 13.50% | 14.47% | 14.31% | 14.74% | 14.71% | 13.95% | -46.59% | 14.46% | 15.01% |
| 财务风险 |
| 流动比率 | 2.26 | 2.23 | 1.97 | 1.51 | 1.47 | 1.81 | 2.87 | 22.54 | 17.55 | 15.69 |
| 速动比率 | 1.70 | 1.62 | 1.36 | 1.03 | 1.00 | 1.23 | 2.33 | 20.23 | 16.25 | 14.07 |
| 现金流量比率 | 0.14 | 0.07 | 0.76 | 0.30 | 0.10 | | 0.17 | -0.15 | -0.48 | -0.19 |
| 资产负债率 | 39.18% | 38.43% | 41.78% | 53.32% | 52.76% | 38.79% | 20.42% | 5.15% | 6.24% | 6.49% |
| 权益乘数 | 1.64 | 1.62 | 1.72 | 2.14 | 2.12 | 1.63 | 1.26 | 1.05 | 1.07 | 1.07 |
| 产权比率 | 0.64 | 0.62 | 0.72 | 1.14 | 1.12 | 0.63 | 0.26 | 0.05 | 0.07 | 0.07 |
| 营运能力 |
| 总资产周转率 | 0.90 | 0.84 | 1.03 | 0.82 | 0.87 | 0.68 | 0.25 | 0.10 | 0.21 | 0.22 |
| 总资产周转天数 | 300 | 322 | 263 | 328 | 312 | 399 | 1091 | 2625 | 1293 | 1219 |
| 存货周转率 | 3.06 | 2.41 | 1.98 | 2.05 | 2.02 | 1.53 | 0.42 | 0.18 | 1.02 | 1.34 |
| 存货周转天数 | 88 | 112 | 136 | 132 | 134 | 176 | 650 | 1525 | 265 | 201 |
| 应收账款周转率 | 1.60 | 1.75 | 2.55 | 1.92 | 2.39 | 2.70 | 1.82 | 0.86 | 1.48 | 1.53 |
| 应收账款周转天数 | 169 | 154 | 106 | 141 | 113 | 100 | 148 | 313 | 183 | 177 |
0
False
SZ300122
智飞生物
/stock/finanalysis/sz300122/
/stock/finanalysis/sz300122/